Similar companies
| Company | Stocktwits Subscribers | |
|---|---|---|
 |
AmgenAMGN |
14,993 0% |
 |
Gilead SciencesGILD |
77,603 0% |
 |
Catalyst PharmaceuticalsCPRX |
15,504 0% |
 |
Inovio PharmaceuticalsINO |
92,220 0% |
 |
Anavex Life SciencesAVXL |
23,933 0% |
Liminatus Pharma Stocktwits Subscriber Count
Liminatus Pharma (LIMN) has 2,093 subscribers on Stocktwits, down 5.1% over the past three months. A shrinking subscriber base can signal cooling retail investor attention.
With 2,093 subscribers, Liminatus Pharma has a smaller Stocktwits following than Amgen (14,993) and Gilead Sciences (77,603).
Unlike daily Stocktwits mentions, which spike around news and earnings, subscriber count reflects sustained, long-term interest from the retail investor community.
How LIMN’s Stocktwits Community Feeds the AI Score
Stocktwits subscriber count is a direct read on the size of the retail investor community tracking LIMN. It is not a stock price on its own, but sustained growth in subscribers can reflect building retail interest. AltIndex feeds Liminatus Pharma’s Stocktwits community into the LIMN AI Score as one of 25+ alternative data signals, weighed against sentiment, Reddit activity, and fundamentals.
For daily discussion volume, see LIMN Stocktwits mentions. For other retail-community metrics, see Reddit subscribers and Reddit mentions.
Month over Month
| Sep 2026 | 2,125 | |
| Aug 2026 | 2,178 | |
| Jul 2026 | 2,196 |
Liminatus Pharma Stocktwits Subscribers: Frequently Asked Questions
Liminatus Pharma (LIMN) has 2,093 subscribers (2K) on Stocktwits, based on AltIndex’s tracking of the stock’s Stocktwits page.
Liminatus Pharma's Stocktwits subscriber base is declining, down 5.1% over the past three months. View the trend chart above for the full history.
Stocktwits subscriber count is a proxy for the size of the retail investor community tracking a stock. Unlike daily mentions, which spike around news, subscriber growth reflects sustained interest. No single data point predicts a stock on its own, which is why AltIndex combines LIMN’s Stocktwits community with sentiment, Reddit activity, and 20+ other signals in its AI Score rather than reading any one signal in isolation.
Liminatus Pharma underperforms its industry peers when it comes to Stocktwits Subscribers, ranking in the 1st percentile.
StockTwits is a social media platform designed specifically for the investing community. It enables investors and traders to share market insights, strategies, and real-time news updates. Essentially, it's a specialized network for financial market discussions, often characterized by brief, tweet-like posts.
Sign up and get more insights on Liminatus Pharma.
See Liminatus Pharma’s complete stocktwits subscribers history
Sign up to unlock 1-year and all-time charts for LIMN, plus 25+ alternative data signals, AI Scores, and real-time alerts.
Get Started for FREE
